Why Earlier CAR-T Conversations Matter in Multiple Myeloma: Perspectives from a Patient and Community Oncologist
A patient and community oncologist share how trust, partnership and shared decision-making shaped a CAR-T journey in multiple myeloma.
In a sponsored episode of Podnosis, Julia P., a multiple myeloma patient, shares her journey with CAR-T therapy alongside Dr. Paresh Patel, her community oncologist. They emphasize the importance of trust, communication, and shared decision-making throughout the treatment process. Julia explains that early exposure to treatment options, including the possibility of a treatment-free interval, influenced her decision to pursue CAR-T therapy.
Dr. Patel highlights the role of community oncologists in coordinating care before, during, and after CAR-T, ensuring patients feel empowered and cared for throughout their journey.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
